MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Haines, W. R.
Right arrow Articles by Egan, T. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Haines, W. R.
Right arrow Articles by Egan, T. M.

Vol. 56, Issue 4, 720-727, October 1999

Properties of the Novel ATP-Gated Ionotropic Receptor Composed of the P2X1 and P2X5 Isoforms

William R. Haines, Gonzalo E. Torres, Mark M. Voigt, and Terrance M. Egan

Department of Pharmacological and Physiological Sciences, St. Louis University School of Medicine, St. Louis, Missouri

We recently reported that a novel hetero-oligomeric P2X receptor is formed from the P2X1 and P2X5 isoforms when coexpressed in human embryonic kidney 293 cells (Torres et al., 1998). A more complete description of the pharmacology of this novel receptor is presented here. A brief application of ATP to a voltage-clamped cell transiently expressing P2X1/5 receptors resulted in a biphasic current that rapidly reached a peak and then decayed to a sustained plateau. Washout of ATP was accompanied by generation and fade of a pronounced tail of inward current. EC50 values were determined from concentration-response curves for a range of agonists. The rank order of agonist potency was ATP >=  2 methylthio ATP > adenosine 5'-O-(3-thiotriphosphate) > alpha ,beta -methylene ATP > ADP > CTP. alpha ,beta -methylene ADP, UTP, GTP, and AMP were ineffective. Only ATP and 2 methylthio ATP were full agonists. IC50 values were determined from concentration-response curves for three commonly used purinergic antagonists. Suramin and pyridoxal phosphate-6-azophenyl-2', 4'-disulfonic acid were equipotent at P2X1 and P2X1/5 receptors; however, the P2X1/5 receptor was much less sensitive to TNP-ATP than was the P2X1 receptor. The amplitude of peak ATP-gated current was relatively insensitive to changes in [Ca2+]O (1-30 mM). Finally, plateau currents were potentiated by low concentrations of pyridoxal phosphate-6-azophenyl-2', 4'-disulfonic acid and by raising [Ca2+]O. These results provide additional information on the pharmacological profile of the recombinant P2X1/5 receptor channel and provide a basis to further evaluate ATP-induced currents in native tissues.


Copyright © 1999 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
J. Neurosci.Home page
U. Lalo, Y. Pankratov, S. P. Wichert, M. J. Rossner, R. A. North, F. Kirchhoff, and A. Verkhratsky
P2X1 and P2X5 Subunits Form the Functional P2X Receptor in Mouse Cortical Astrocytes
J. Neurosci., May 21, 2008; 28(21): 5473 - 5480.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
G. Burnstock
Physiology and Pathophysiology of Purinergic Neurotransmission
Physiol Rev, April 1, 2007; 87(2): 659 - 797.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. Fabbretti, E. Sokolova, L. Masten, M. D'Arco, A. Fabbro, A. Nistri, and R. Giniatullin
Identification of Negative Residues in the P2X3 ATP Receptor Ectodomain as Structural Determinants for Desensitization and the Ca2+-sensing Modulatory Sites
J. Biol. Chem., December 17, 2004; 279(51): 53109 - 53115.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
K. Tsuzuki, A. Ase, P. Seguela, T. Nakatsuka, C.-Y. Wang, J.-X. She, and J. G. Gu
TNP-ATP-Resistant P2X Ionic Current on the Central Terminals and Somata of Rat Primary Sensory Neurons
J Neurophysiol, June 1, 2003; 89(6): 3235 - 3242.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
T. Nakatsuka, K. Tsuzuki, J. X. Ling, H. Sonobe, and J. G. Gu
Distinct Roles of P2X Receptors in Modulating Glutamate Release at Different Primary Sensory Synapses in Rat Spinal Cord
J Neurophysiol, June 1, 2003; 89(6): 3243 - 3252.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
S. S. Wildman, S. G. Brown, M. Rahman, C. A. Noel, L. Churchill, G. Burnstock, R. J. Unwin, and B. F. King
Sensitization by Extracellular Ca2+ of Rat P2X5 Receptor and Its Pharmacological Properties Compared with Rat P2X1.
Mol. Pharmacol., October 1, 2002; 62(4): 957 - 966.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
R. A. North
Molecular Physiology of P2X Receptors
Physiol Rev, October 1, 2002; 82(4): 1013 - 1067.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
O. Cinkilic, B. F. King, M. van der Giet, H. Schluter, W. Zidek, and G. Burnstock
Selective Agonism of Group I P2X Receptors by Dinucleotides Dependent on a Single Adenine Moiety
J. Pharmacol. Exp. Ther., October 1, 2001; 299(1): 131 - 136.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
T. Nakatsuka and J. G. Gu
ATP P2X Receptor-Mediated Enhancement of Glutamate Release and Evoked EPSCs in Dorsal Horn Neurons of the Rat Spinal Cord
J. Neurosci., September 1, 2001; 21(17): 6522 - 6531.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
M. Liu, B. F. King, P. M. Dunn, W. Rong, A. Townsend-Nicholson, and G. Burnstock
Coexpression of P2X3 and P2X2 Receptor Subunits in Varying Amounts Generates Heterogeneous Populations of P2X Receptors That Evoke a Spectrum of Agonist Responses Comparable to That Seen in Sensory Neurons
J. Pharmacol. Exp. Ther., March 1, 2001; 296(3): 1043 - 1050.
[Abstract] [Full Text]


Home page
Pharmacol. Rev.Home page
B. S. Khakh, G. Burnstock, C. Kennedy, B. F. King, R. A. North, P. Seguela, M. Voigt, and P. P. A. Humphrey
International Union of Pharmacology. XXIV. Current Status of the Nomenclature and Properties of P2X Receptors and Their Subunits
Pharmacol. Rev., March 1, 2001; 53(1): 107 - 118.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
B. F. King, A. Townsend-Nicholson, S. S. Wildman, T. Thomas, K. M. Spyer, and G. Burnstock
Coexpression of Rat P2X2 and P2X6 Subunits in Xenopus Oocytes
J. Neurosci., July 1, 2000; 20(13): 4871 - 4877.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
W. R. Haines, K. Migita, J. A. Cox, T. M. Egan, and M. M. Voigt
The First Transmembrane Domain of the P2X Receptor Subunit Participates in the Agonist-induced Gating of the Channel
J. Biol. Chem., August 24, 2001; 276(35): 32793 - 32798.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1999 by the American Society for Pharmacology and Experimental Therapeutics